Kamada (KMDA) Debt Ratio (2016 - 2026)

Kamada (KMDA) posted quarterly Debt Ratio of 0.03 for Q1 2026, down 19.51% year-on-year from 0.03 in Q1 2025, and up 6.05% on a QoQ basis from 0.03 in Q4 2025.

Kamada (KMDA) Debt Ratio (2016 - 2026) Analysis & Trends

Kamada (KMDA) has reported Debt Ratio for 11 consecutive years, with 0.03 the latest figure, recorded in Q1 2026.

  • Quarterly Debt Ratio fell 19.51% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (down 19.51% YoY) and the FY2025 annual result came in at 0.03, down 4.2% from the prior year.
  • Debt Ratio grew to 0.03 in Q1 2026 per KMDA's latest filing, from 0.03 in the prior quarter.
  • Over the last five years, Debt Ratio for KMDA reached as high as 0.13 in Q4 2022 and fell as low as 0.0 in Q4 2023.
  • A 5-year average of 0.04 and a median of 0.03 in 2026 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 122811.49% — and 2023, when it slumped 99.97%.
  • Year by year, Debt Ratio stood at 0.13 in 2022, then sank by 99.97% to 0.0 in 2023, then surged by 64627.53% to 0.03 in 2024, then dropped by 4.2% to 0.03 in 2025, then advanced by 6.05% to 0.03 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.03, 0.03, and 0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 0.26
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.42
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.60
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.29
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 0.10
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.29
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 0.03

Historic Data

Download Data
DateValue
Mar 31, 2026 0.03
Dec 31, 2025 0.03
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.03
Dec 31, 2024 0.03
Sep 30, 2024 0.03
Jun 30, 2024 0.04
Mar 31, 2024 0.04
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.11
Mar 31, 2023 0.00
Dec 31, 2022 0.13
Sep 30, 2022 0.00
Jun 30, 2022 0.12
Mar 31, 2022 0.12
Dec 31, 2021 0.11
Sep 30, 2021 0.00
Jun 30, 2021 0.00